Pigs naturally exposed to porcine circovirus type 2 (PCV2) generate antibody responses capable to neutralise PCV2 isolates of different genotypes and geographic origins

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Kurtz, Sherry ^a,b   Grau Roma, Llorenç ^a,c,d   Cortey, Martí ^a,e   Fort, Maria ^a,f   Rodríguez, Fernando ^a   Sibila, Marina ^a   Segalés, Joaquim ^a,c  

^a CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^e INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^f Zoetis Manufacturing and Research Spain SL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL DISEASE; ARTICLE; CIRCOVIRUS; ENZYME IMMUNOASSAY; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; POSTWEANING MULTISYSTEMIC WASTING SYNDROME; SEQUENCE ALIGNMENT; SERODIAGNOSIS; SWINE; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CIRCOVIRUS; GENOTYPE; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PORCINE POSTWEANING MULTISYSTEMIC WASTING SYNDROME; SEQUENCE ALIGNMENT; SWINE; VIRAL PROTEINS;

EID: 84899484979     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-45-29     Document Type: Article

References (44)

1. A very small porcine virus with circular single-stranded DNA. Tischer I, Gelderblom H, Vettermann W, Koch MA, Nature 1982 295 64 66 10.1038/295064a0 7057875
2. Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. Meehan BM, McNeilly F, Todd D, Kennedy S, Jewhurst VA, Ellis JA, Hassard LE, Clark EG, Haines DM, Allan GM, J Gen Virol 1998 79 2171 2179 9747726
3. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Segalés J, Virus Res 2012 164 10 19 10.1016/j.virusres.2011.10.007 22056845
4. Porcine circovirus type 2 associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. Opriessnig T, Meng XJ, Halbur PG, J Vet Diagn Invest 2007 19 591 615 10.1177/104063870701900601 17998548
5. Porcine circovirus diseases. Segalés J, Allan GM, Domingo M, Anim Health Res Rev 2005 6 119 142 10.1079/AHR2005106 16583778
6. Postweaning multisystemic wasting syndrome. Clark E, Proceedings of the Annual Meeting of the American Association of Swine Practitioners 1997 499 501
7. Postweaning multisystemic wasting syndrome (PMWS): preliminary epidemiology and clinical presentation. Harding J, Proceedings of the American Association of Swine Practitioners 1997 503 504
8. Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2. Grau-Roma L, Fraile L, Segalés J, Vet J 2011 187 23 32 10.1016/j.tvjl.2010.01.018 20211570
9. Transcription analysis of porcine circovirus (PCV). Mankertz J, Buhk HJ, Blaess G, Mankertz A, Virus Genes 1998 16 267 276 10.1023/A:1008022521329 9654680
10. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. Nawagitgul P, Morozov I, Bolin SR, Harms PA, Sorden SD, Paul PS, J Gen Virol 2000 81 2281 2287 10950986
11. The ORF3 protein of porcine circovirus type 2 is involved in viral pathogenesis in vivo. Liu J, Chen I, Du Q, Chua H, Kwang J, J Virol 2006 80 5065 5073 10.1128/JVI.80.10.5065-5073.2006 16641298
12. The natural history of porcine circovirus type 2: from an inoffensive virus to a devastating swine disease? Segalés J, Kekarainen T, Cortey M, Vet Microbiol 2013 165 13 20 10.1016/j.vetmic.2012.12.033 23380460
13. Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Cheung AK, Lager KM, Kohutyuk OI, Vincent AL, Henry SC, Baker RB, Rowland RR, Dunham AG, Arch Virol 2007 152 1035 1044 10.1007/s00705-006-0909-6 17219018
14. The emergence of porcine circovirus 2b genotype (PCV-2b) in swine in Canada. Gagnon CA, Tremblay D, Tijssen P, Venne MH, Houde A, Elahi SM, Can Vet J 2007 48 811 819 17824323
15. Genomic analysis of PCV2 isolates from Danish archives and a current PMWS case-control study supports a shift in genotypes with time. Dupont K, Nielsen EO, Baekbo P, Larsen LE, Vet Microbiol 2008 128 56 64 10.1016/j.vetmic.2007.09. 016 17996404
16. Phylogenetic analysis of porcine circovirus type 2 (PCV2) pre- and post-epizootic postweaning multisystemic wasting syndrome (PMWS). Timmusk S, Wallgren P, Brunborg IM, Wikstrom FH, Allan G, Meehan B, McMenamy M, McNeilly F, Fuxler L, Belak K, Põdersoo D, Saar T, Berg M, Fossum C, Virus Genes 2008 36 509 520 10.1007/s11262-008-0217-1 18343985
17. A new emerging genotype subgroup within PCV-2b dominates the PMWS epizooty in Switzerland. Wiederkehr DD, Sydler T, Buergi E, Haessig M, Zimmermann D, Pospischil A, Brugnera E, Sidler X, Vet Microbiol 2009 136 27 35 10.1016/j.vetmic.2008.10.028 19081207
18. Genetic characterization and phylogenetic analysis of porcine circovirus type 2 (PCV2) strains from cases presenting various clinical conditions. Larochelle R, Magar R, D'Allaire S, Virus Res 2002 90 101 112 10.1016/S0168-1702(02)00141-7 12457966
19. Effects of porcine circovirus type 2 (PCV2) maternal antibodies on experimental infection of piglets with PCV2. McKeown NE, Opriessnig T, Thomas P, Guenette DK, Elvinger F, Fenaux M, Halbur PG, Meng XJ, Clin Diagn Lab Immunol 2005 12 1347 1351 16275955
20. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. Meerts P, Misinzo G, Lefebvre D, Nielsen J, Botner A, Kristensen CS, Nauwynck HJ, BMC Vet Res 2006 2 6 10.1186/1746-6148-2-6 16445856
21. Detection of neutralizing antibodies in postweaning multisystemic wasting syndrome (PMWS)-affected and non-PMWS-affected pigs. Fort M, Olvera A, Sibila M, Segalés J, Mateu E, Vet Microbiol 2007 125 244 255 10.1016/j.vetmic.2007.06.004 17611048
22. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins. Fort M, Sibila M, Allepuz A, Mateu E, Roerink F, Segalés J, Vaccine 2008 26 1063 1071 10.1016/j.vaccine.2007.12.019 18237827
23. Development of cell-mediated immunity to porcine circovirus type 2 (PCV2) in caesarean-derived, colostrum-deprived piglets. Fort M, Fernandes LT, Nofrarias M, Diaz I, Sibila M, Pujols J, Mateu E, Segalés J, Vet Immunol Immunopathol 2009 129 101 107 10.1016/j.vetimm.2008.12.024 19167096
24. Cellular adaptive immune response against porcine circovirus type 2 in subclinically infected pigs. Steiner E, Balmelli C, Gerber H, Summerfield A, McCullough K, BMC Vet Res 2009 5 45 10.1186/1746-6148-5-45 20028550
25. Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes. Mahe D, Blanchard P, Truong C, Arnauld C, Le Cann P, Cariolet R, Madec F, Albina E, Jestin A, J Gen Virol 2000 81 1815 1824 10859388
26. Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. Lekcharoensuk P, Morozov I, Paul PS, Thangthumniyom N, Wajjawalku W, Meng XJ, J Virol 2004 78 8135 8145 10.1128/JVI.78.15.8135-8145.2004 15254185
27. Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Shang SB, Jin YL, Jiang XT, Zhou JY, Zhang X, Xing G, He JL, Yan Y, Mol Immunol 2009 46 327 334 10.1016/j.molimm.2008.10.028 19059648
28. Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2. Huang LP, Lu YH, Wei YW, Guo LJ, Liu CM, BMC Microbiol 2011 11 188 10.1186/1471-2180-11-188 21859462
29. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Fachinger V, Bischoff R, Jedidia SB, Saalmuller A, Elbers K, Vaccine 2008 26 1488 1499 10.1016/j.vaccine.2007.11.053 18304705
30. Antigenic differences among porcine circovirus type 2 strains, as demonstrated by the use of monoclonal antibodies. Lefebvre DJ, Costers S, Van Doorsselaere J, Misinzo G, Delputte PL, Nauwynck HJ, J Gen Virol 2008 89 177 187 10.1099/vir.0.83280-0 18089741
31. Production, characterisation and applications of monoclonal antibodies to porcine circovirus 2. McNeilly F, McNair I, Mackie DP, Meehan BM, Kennedy S, Moffett D, Ellis J, Krakowka S, Allan GM, Arch Virol 2001 146 909 922 10.1007/s007050170124 11448029
32. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection. Opriessnig T, Ramamoorthy S, Madson DM, Patterson AR, Pal N, Carman S, Meng XJ, Halbur PG, J Gen Virol 2008 89 2482 2491 10.1099/vir.0.2008/001081-0 18796717
33. Single amino acid mutations in the capsid switch the neutralization phenotype of porcine circovirus 2. Saha D, Lefebvre DJ, Ooms K, Huang L, Delputte PL, Van Doorsselaere J, Nauwynck HJ, J Gen Virol 2012 93 1548 1555 10.1099/vir.0.042085-0 22492916
34. Porcine circovirus type 2 (PCV2) Cap and Rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection. Fort M, Sibila M, Nofrarias M, Perez-Martin E, Olvera A, Mateu E, Segalés J, Vet Immunol Immunopathol 2010 137 226 234 10.1016/j.vetimm.2010.05.013 20566220
35. Genetic characterization of type 2 porcine circovirus (PCV-2) from pigs with postweaning multisystemic wasting syndrome in different geographic regions of North America and development of a differential PCR-restriction fragment length polymorphism assay to detect and differentiate between infections with PCV-1 and PCV-2. Fenaux M, Halbur PG, Gill M, Toth TE, Meng XJ, J Clin Microbiol 2000 38 2494 2503 10878032
36. Infection, excretion and seroconversion dynamics of porcine circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Grau-Roma L, Hjulsager CK, Sibila M, Kristensen CS, Lopez-Soria S, Enoe C, Casal J, Botner A, Nofrarias M, Bille-Hansen V, Fraile L, Baekbo P, Segalés J, Larsen LE, Vet Microbiol 2009 135 272 282 10.1016/j.vetmic.2008.10.007 19027247
37. Risk factors associated with pleuritis and cranio-ventral pulmonary consolidation in slaughter-aged pigs. Fraile L, Alegre A, Lopez-Jimenez R, Nofrarias M, Segalés J, Vet J 2010 184 326 333 10.1016/j.tvjl.2009.03.029 19527939
38. Serum antibodies to porcine circovirus type 1 and type 2 in pigs with and without PMWS. Rodriguez-Arrioja GM, Segalés J, Balasch M, Rosell C, Quintant J, Folch JM, Plana-Duran J, Mankertz A, Domingo M, Vet Rec 2000 146 762 764 10.1136/vr.146.26.762 10909911
39. Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Olvera A, Cortey M, Segalé J, Virology 2007 357 175 185 10.1016/j.virol.2006.07.047 16963096
40. A proposal on porcine circovirus type 2 (PCV2) genotype definition and their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence. Grau-Roma L, Crisci E, Sibila M, Lopez-Soria S, Nofrarias M, Cortey M, Fraile L, Olvera A, Segalés J, Vet Microbiol 2008 128 23 35 10.1016/j.vetmic.2007.09.007 17976930
41. Infectious agents associated with respiratory diseases in 125 farrow-to-finish pig herds: a cross-sectional study. Fablet C, Marois-Crehan C, Simon G, Grasland B, Jestin A, Kobisch M, Madec F, Rose N, Vet Microbiol 2012 157 152 163 10.1016/j.vetmic.2011.12.015 22226820
42. Dynamics of porcine circovirus type 2 infection in a herd of pigs with postweaning multisystemic wasting syndrome. Rodriguez-Arrioja GM, Segalés J, Calsamiglia M, Resendes AR, Balasch M, Plana-Duran J, Casal J, Domingo M, Am J Vet Res 2002 63 354 357 10.2460/ajvr.2002.63.354 11911570
43. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA. Shen HG, Halbur PG, Opriessnig T, J Gen Virol 2012 93 1345 1355 10.1099/vir.0.039552-0 22398315
44. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection. Opriessnig T, O'Neill K, Gerber PF, de Castro AM, Gimenez-Lirola LG, Beach NM, Zhou L, Meng XJ, Wang C, Halbur PG, Vaccine 2013 31 487 494 10.1016/j.vaccine.2012.11.030 23174198